Spyre Therapeutics Long Term Deferred Assets (Quarterly) Analysis

Spyre Therapeutics, Inc. (SYRE)

44.21 +1.00 (+2.31%) USD | NASDAQ | Feb 23, 16:00

44.21 0.00 (0.00%) After-Hours: 16:28

View Long Term Deferred Assets (Quarterly) for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

PTC Therapeutics, Inc.	--
Tandem Diabetes Care, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--